PWM
HALO icon

Parkworth Wealth Management’s Halozyme HALO Stock Holding History

Parkworth Wealth Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$364 Buy
7
+3
+75% +$171 ﹤0.01% 731
2025
Q1 		$255 Buy
4
+2
+100% +$116 ﹤0.01% 646
2024
Q4 		$96 Buy
+2
New +$103 ﹤0.01% 990

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Parkworth Wealth Management's HALO Position: Q2 2025 in Review

Parkworth Wealth Management increased its Halozyme (HALO) stake by 75% in Q2 2025, buying an estimated $171 and bringing the position to 7 shares worth $364. The position accounts for ﹤0.01% of the portfolio, ranked #731.

Parkworth Wealth Management first reported a position in HALO in Q4 2024 and has held it in 3 quarters since. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

  • Parkworth Wealth Management held 7 shares of Halozyme worth $364 as of Q2 2025.
  • Parkworth Wealth Management bought 3 Halozyme shares in Q2 2025, an estimated $171.
  • Halozyme made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #731 holding.
  • Parkworth Wealth Management first reported a position in Halozyme in Q4 2024 and has held it in 3 quarters since.
  • 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.